[8-K] Linde plc Ordinary Share Reports Material Event

Rhea-AI Filing Summary

Parke Bancorp (PKBK) filed an 8-K announcing that its Board has extended the existing stock repurchase program by six months. The authorization, unveiled on 2 Aug 2024, permits the company to buy back up to 5 % of outstanding common shares on the open market. The expiration date moves from 2 Aug 2025 to 2 Feb 2026, or earlier if the 5 % ceiling is reached.

Repurchases will be executed under Rule 10b-18 and remain subject to prevailing price levels, regulatory constraints and market conditions. No changes were made to the size of the authorization. The extension signals management’s confidence in intrinsic value, offers potential EPS accretion through share-count reduction and provides a floor of incremental demand for the stock.

Positive

• Share repurchase program extended to 2 Feb 2026, maintaining potential reduction of up to 5 % of shares outstanding
• Continued capital return may support EPS growth and signal board confidence

Negative

• None.

Insights

Financial Analyst

TL;DR: Six-month buyback extension adds potential EPS tailwind and signals confidence; modest but positive for PKBK valuation.

The Board’s decision to prolong the 5 % buyback window to February 2026 keeps a capital-return mechanism active during uncertain rate and credit conditions. While the authorization size is unchanged, an active bid for shares can mitigate downside volatility and modestly enhance per-share metrics if fully executed. Because PKBK is a community bank with a relatively small float, a 5 % reduction could be meaningful to liquidity and ROE. Execution risk (pricing, regulatory timing) remains, but overall impact is incrementally favorable.

0001707925false00017079252025-07-292025-07-290001707925dei:OtherAddressMember2025-07-292025-07-29iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (Date of earliest event reported): July 29, 2025

Linde plc

(Exact name of registrant as specified in its charter)

Ireland		001-38730		98-1448883
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

   10 Riverview Dr. Danbury, Connecticut United States 06810 Forge 43 Church Street West Woking, Surrey GU21 6HT United Kingdom

(Address of principal executive offices) (Zip Code)

+44 1483 242200

(Registrant’s telephone numbers, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Ordinary shares (€0.001 nominal value per share)		LIN		Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 5.07 Submission of Matters to a Vote of Security Holders

The Linde plc Annual General Meeting of Shareholders was held on July 29, 2025 (the “AGM”), at which shareholders voted upon the items set forth below. The total number of shares that were present or represented by proxy at the Annual Meeting was 393,235,938 which was 83.53% of the shares outstanding and entitled to vote and which constituted a quorum. The final voting results of the items submitted to a vote of the shareholders are set forth below.

Proposal 1

The ten nominees for election as a director were elected to serve until the 2026 annual general meeting of shareholders and until his or her successor is elected and qualified. The vote results were as follows:

Director Nominees			Shares For				Shares Against				Shares Abstained				Broker Non-Votes				% of Votes Cast For
Stephen F. Angel			361,831,851				12,291,627				311,942				18,800,518				96.71	%
Sanjiv Lamba			372,676,475				1,437,629				321,316				18,800,518				99.61	%
Prof DDr. Ann-Kristin Achleitner			366,586,741				7,526,010				322,669				18,800,518				97.98	%
Dr. Thomas Enders			370,254,026				3,319,679				861,715				18,800,518				99.11	%
Hugh Grant			367,577,067				6,590,496				267,857				18,800,518				98.23	%
Joe Kaeser			357,634,449				16,532,637				268,334				18,800,518				95.58	%
Victoria E. Ossadnik			348,715,791				25,463,754				255,875				18,800,518				93.19	%
Paula Rosput Reynolds			373,082,950				1,090,595				261,875				18,800,518				99.70	%
Alberto Weisser			368,469,248				5,700,927				265,245				18,800,518				98.47	%
Robert L. Wood			366,922,087				7,258,861				254,472				18,800,518				98.06	%

Proposal 2a

Shareholders ratified, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PWC”) as the independent auditor by the votes set forth below.

Shares Voted For		Shares Voted Against		Shares Abstained		Broker Non-Votes
363,226,295		28,671,074		1,338,569		N/A
(92.36% of votes cast)		(7.29% of votes cast)

2

Proposal 2b

Shareholders approved the authorization of the Board, acting through the Audit Committee, to determine PWC’s remuneration by the votes set forth below.

Shares Voted For		Shares Voted Against		Shares Abstained		Broker Non-Votes
384,952,458		6,914,355		1,338,569		N/A
(97.89% of votes cast)		(1.76% of votes cast)

Proposal 3

Shareholders approved, on an advisory and non-binding basis, the compensation of Linde plc’s Named Executive Officers as disclosed in the 2025 proxy statement by the votes set forth below.

Shares Voted For		Shares Voted Against		Shares Abstained		Broker Non-Votes
352,025,829		21,998,013		411,578		18,800,518
(94.01% of votes cast)		(5.87% of votes cast)

Proposal 4

Shareholders approved, on an advisory and nonbinding basis, the frequency of holding future advisory shareholder votes on the compensation of Linde plc's Named Executive Officers as one (1) year.

1 Year		2 Years		3 Years		Shares Abstained		Broker Non-Votes
370,551,908		132,611		3,463,416		287,485		18,800,518
(98.96% of votes cast)		(0.04% of votes cast)		(0.92% of votes cast)

Proposal 5

Shareholders approved the proposal to determine the price range at which Linde plc can re-allot shares that it acquires as treasury shares under Irish law.

Shares Voted For		Shares Voted Against		Shares Abstained		Broker Non-Votes
391,532,709		868,351		834,878		N/A
(99.56% of votes cast)		(0.22% of votes cast)

Proposal 6

No vote is being reported for a shareholder proposal that requested an annual report regarding the alignment of Linde’s lobbying and trade association activities with the Linde’s 2050 climate neutrality ambition. Neither the shareholder proponent nor a representative attended the AGM to present the proposal as required, and therefore, the proposal was not acted upon by the shareholders.

3

ITEM 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed.

Exhibit No.		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

4

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	LINDE PLC
	By:	/s/ Guillermo Bichara
	Name:	Guillermo Bichara
	Title:	Chief Legal Officer

Date: August 1, 2025

5

FAQ

What did Parke Bancorp (PKBK) announce on 1 Aug 2025?

The Board extended its share repurchase program by six months, now expiring 2 Feb 2026.

How many shares can PKBK repurchase under the program?

The authorization allows buybacks of up to 5 % of the company’s outstanding common stock.

When will the extended buyback program end?

Unless the 5 % limit is reached sooner, the program expires on 2 February 2026.

Under which SEC rule will PKBK conduct the repurchases?

Purchases are planned in accordance with Rule 10b-18 of the Securities Exchange Act of 1934.

Why might the buyback extension matter to investors?

An active buyback can support the share price and improve EPS by reducing the number of shares outstanding.